Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Takuho Ishii"'
Publikováno v:
ACS Omega, Vol 8, Iss 39, Pp 36261-36268 (2023)
Externí odkaz:
https://doaj.org/article/95bbf68833854615b33af03d82e52683
Publikováno v:
European Journal of Mass Spectrometry. 28:94-103
Exemestane is one of the aromatase inhibitors and has been used to treat breast cancer by lowering estrogen levels. Accurate quantification of exemestane is important to set an optimal dose, and thus a simple assay for exemestane is developed by ultr
Autor:
Tsuyoshi Mayumi, Shinya Hosaka, Yutaka Yasuda, Takuho Ishii, Makoto Niwa, Tatsuya Yamakawa, Ayumi Ueda, Naoko Nakai
Publikováno v:
Bioanalysis. 12:7-10
Autor:
Tsuyoshi Mayumi, Takuho Ishii, Shinya Hosaka, Keita Ono, Yutaka Yasuda, Makoto Niwa, Naoko Nakai, Saori Kuriyama, Tatsuya Yamakawa
Publikováno v:
Bioanalysis. 10:1553-1556
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 157
E6005, a novel phosphodiesterase 4 inhibitor, is currently under clinical development for the treatment of atopic dermatitis. To support pediatric clinical trials, the dried blood spot assay for simultaneous determination of E6005 and its main metabo
Autor:
Koichiro Hotta, Kenji Kita, Takuho Ishii, Kenji Sakamaki, Takuya Ueno, Kazutomi Kusano, Yuji Mano
Publikováno v:
Biomedical Chromatography. 29:1343-1349
A simple and reproducible bioanalytical method for the determination of gemcitabine in human plasma treated with tetrahydrouridine (THU) was developed and validated using a hydrophilic interaction ultra-performance liquid chromatography with tandem m
Publikováno v:
Biomedical Chromatography. 29:1399-1405
A simple and reproducible bioanalytical method for the determination of flecainide in human plasma was developed and validated using an ultra-performance liquid chromatography with tandem mass spectrometry (UPLC-MS/MS) to obtain higher sensitivity th
Autor:
Naohiro Nishimura, Akiko Toda, Naoko Nakai, Takuho Ishii, Yutaka Yasuda, Makoto Niwa, Keita Ono, Tatsuya Yamakawa, Takahide Uchimura, Nozomu Koseki, Hiroko Ashizawa, Kuretake Soejima, Saori Kuriyama, Tsuyoshi Mayumi
Publikováno v:
Bioanalysis. 9(13)
Publikováno v:
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
E6005, a novel phosphodiesterase 4 inhibitor, is currently under clinical development for the treatment of atopic dermatitis. As ER-392710 (M11), a hydrolyzed metabolite, is a main metabolite, a simultaneous assay method for quantification of E6005 a
Publikováno v:
Biomedical chromatography : BMC. 29(9)
A simple and reproducible bioanalytical method for the determination of flecainide in human plasma was developed and validated using an ultra-performance liquid chromatography with tandem mass spectrometry (UPLC-MS/MS) to obtain higher sensitivity th